Equity Overview
Price & Market Data
Price: $3.50
Daily Change: +$0.30 / 8.57%
Range: $3.14 - $3.58
Market Cap: $7,842,248
Volume: 237,750
Performance Metrics
1 Week: 9.63%
1 Month: -17.33%
3 Months: -20.67%
6 Months: -71.09%
1 Year: -89.84%
YTD: -18.29%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country: Germany
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product. The company was founded in 2008 and is based in Mainz, Germany.